Related Experiment Video
Updated: Aug 11, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
Update on the pathogenesis and immunotherapy of esophageal squamous cell carcinoma
1Hominem (Non-Governmental Organization), Lima, Peru.
Abstract:
The esophageal squamous cell carcinoma (ESCC) is the prevailing histology subtype of esophageal cancer and is distinguished by its high mortality and its geographic differences in regards to its incidence. The exact cause of this neoplasia is still unknown in spite of all the research made in this area. Our understanding about pathogenesis, epidemiology and behaviour of the ESCC is still in progress thanks to the advances on the field of molecular biology. Some of these advances include the research of etiopathogenesis (virus, as the human papillomavirus, and the genes susceptible to cancer), genes associated with tumors (oncogenes, tumor suppressor genes), as well as new forms of neoadjuvant immunotherapy for the treatment of this neoplasia.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...

